GR920100471A - Κα?αρισμένη ανοσογλοβουλίνη. - Google Patents

Κα?αρισμένη ανοσογλοβουλίνη.

Info

Publication number
GR920100471A
GR920100471A GR920100471A GR920100471A GR920100471A GR 920100471 A GR920100471 A GR 920100471A GR 920100471 A GR920100471 A GR 920100471A GR 920100471 A GR920100471 A GR 920100471A GR 920100471 A GR920100471 A GR 920100471A
Authority
GR
Greece
Prior art keywords
reducing conditions
recombinant antibody
reduced sample
purified
primary peaks
Prior art date
Application number
GR920100471A
Other languages
English (en)
Inventor
Geoffrey Allen
Paul Ian Nicholas Ramage
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10683866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR920100471(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR920100471A publication Critical patent/GR920100471A/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Καθαρισμένο παρασκεύασμα ανασυνδυασμένου αντισώματος το οποίο σε χρωματογραφία δι'αποκλεισμού κατά μεγέθη, εμφανίζει μία μονή κορυφή υπό μη-αναγωγικες συνθήκες και δύο πρωτεύουσες κορυφές υπό αναγωγικές συνθήκες. Σε συμβατική SDS-PAGE:μία κύρια ταινία με την χρησιμοποίηση μη-ανηγμένου δείγματος και δύο κύριες ταινίες με την χρησιμοποίηση ανηγμένου δείγματος. Σε HPLC αντίστροφης φάσεως: μία μονή αιχμηρή κορυφή υπό μη-αναγωγικές συνθήκες και δύο πρωτεύουσες κορυφές υπό αναγωγικές συνθήκες και έχει μία ειδική δραστικότητα μεγαλύτερη του 0,8 κιλού ανά μονάδα/mg. Επίσης η μέθοδος καθαρισμού αντισώματος ανασυνδυασμού, συνθέσεις οι οποίες περιέχουν ένα τέτοιο καθαρισμένο παρασκεύασμα, και χρήσεις αυτών. ω
GR920100471A 1990-10-17 1992-10-20 Κα?αρισμένη ανοσογλοβουλίνη. GR920100471A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022547A GB9022547D0 (en) 1990-10-17 1990-10-17 Purified immunoglobulin

Publications (1)

Publication Number Publication Date
GR920100471A true GR920100471A (el) 1994-06-30

Family

ID=10683866

Family Applications (3)

Application Number Title Priority Date Filing Date
GR910100425A GR910100425A (el) 1990-10-17 1991-10-16 Κα?αρισμένη ανοσογλοβουλίνη.
GR920100471A GR920100471A (el) 1990-10-17 1992-10-20 Κα?αρισμένη ανοσογλοβουλίνη.
GR980400777T GR3026588T3 (en) 1990-10-17 1998-04-10 PURIFIED IgG ANTIBODIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR910100425A GR910100425A (el) 1990-10-17 1991-10-16 Κα?αρισμένη ανοσογλοβουλίνη.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR980400777T GR3026588T3 (en) 1990-10-17 1998-04-10 PURIFIED IgG ANTIBODIES

Country Status (29)

Country Link
US (1) US5644036A (el)
EP (1) EP0504363B2 (el)
JP (1) JP2638680B2 (el)
KR (2) KR960015399B1 (el)
AT (2) ATA900791A (el)
AU (3) AU658926B2 (el)
BE (1) BE1004226A5 (el)
BR (1) BR1100358A (el)
CA (1) CA2069481C (el)
CH (2) CH681305A5 (el)
DE (1) DE69128774T3 (el)
DK (1) DK0504363T4 (el)
ES (2) ES2081742B1 (el)
FI (2) FI110003B (el)
FR (2) FR2668164A1 (el)
GB (2) GB9022547D0 (el)
GR (3) GR910100425A (el)
HU (1) HUT64601A (el)
IE (1) IE913560A1 (el)
IL (3) IL102726A (el)
IT (1) IT1250064B (el)
LU (1) LU88122A1 (el)
MX (1) MX9203794A (el)
MY (2) MY136210A (el)
NZ (2) NZ244114A (el)
PT (2) PT99248B (el)
TW (1) TW283710B (el)
WO (1) WO1992007084A1 (el)
ZA (2) ZA918259B (el)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
CA2120911A1 (en) * 1991-10-15 1993-04-29 Geoffrey Hale Medicaments
GB9125768D0 (en) * 1991-12-04 1992-02-05 Hale Geoffrey Therapeutic method
GB9300501D0 (en) * 1993-01-09 1993-03-03 Wellcome Found Purification of immunoglobulin
KR19990036028A (ko) † 1995-08-01 1999-05-25 다니엘 케르니 일본뇌염 백신의 공업적인 생산방법 및 이에 의한 백신
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
BRPI9715219B8 (pt) * 1996-02-09 2015-07-07 Abbvie Biotechnology Ltd Vetor recombinante de expressão, e célula hospedeira procariótica.
GB9603256D0 (en) * 1996-02-16 1996-04-17 Wellcome Found Antibodies
US20030023043A1 (en) * 2000-03-02 2003-01-30 Kazuhisa Uchida Method of separating and purifying protein
WO2002072615A1 (fr) * 2001-03-09 2002-09-19 Chugai Seiyaku Kabushiki Kaisha Methode de purification de proteines
NZ530025A (en) * 2001-06-05 2005-06-24 Inst Genetics Llc Methods for purifying highly anionic proteins
GB0220894D0 (en) * 2002-09-09 2002-10-16 Millipore Uk Ltd Method of separation
SI2261230T1 (sl) 2002-09-11 2017-08-31 Chugai Seiyaku Kabushiki Kaisha Postopek čiščenja proteinov
WO2004035618A2 (en) 2002-10-15 2004-04-29 Intercell Ag Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
JP2007515492A (ja) * 2003-12-22 2007-06-14 ジェンザイム コーポレイション 糖尿病の抗ｃｄ５２抗体治療法
CN104610422A (zh) * 2005-03-11 2015-05-13 惠氏公司 弱分配层析的方法
EP3521311A1 (en) 2008-04-11 2019-08-07 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
MY160126A (en) 2009-05-13 2017-02-28 Genzyme Corp Anti-human cd52 immunoglobulins
CA2761885A1 (en) 2009-05-13 2010-11-18 Genzyme Corporation Methods and compositions for treating lupus
EP2695889A1 (en) * 2009-12-29 2014-02-12 Dr. Reddy's Laboratories Limited Protein purification by ion exchange
EP2583973B1 (en) 2010-06-21 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
CA2819356C (en) 2010-11-30 2023-01-24 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
GB201109238D0 (en) * 2011-06-01 2011-07-13 Antitope Ltd Antibodies
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
WO2014035475A1 (en) 2012-09-02 2014-03-06 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
AU2013381687A1 (en) 2013-03-12 2015-09-24 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
AR095199A1 (es) 2013-03-15 2015-09-30 Genzyme Corp Anticuerpos anti-cd52
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
RU2714967C2 (ru) 2013-12-27 2020-02-21 Чугаи Сейяку Кабусики Кайся Способ очистки антител с низкой изоэлектрической точкой
NZ730607A (en) 2014-12-19 2022-07-01 Chugai Pharmaceutical Co Ltd Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
JP6823596B2 (ja) 2015-07-31 2021-02-03 中外製薬株式会社 アニオン性ポリマーによる抗体を含有する組成物の精製方法
EP3487868A4 (en) 2016-07-25 2020-07-29 Cephalon, Inc. WASHING PAD FOR AFFINITY CHROMATOGRAPHY
CN109689099B (zh) 2016-08-05 2023-02-28 中外制药株式会社 用于预防或治疗il-8相关疾病的组合物
EP3950099A4 (en) 2019-03-29 2022-05-18 Asahi Kasei Medical Co., Ltd. PROTEINS PURIFICATION PROCEDURES
EP3954725B1 (en) 2019-04-08 2024-03-06 Asahi Kasei Medical Co., Ltd. Polyamide medium for purifying protein-containing solution and method for producing polyamide medium
KR20210149779A (ko) 2019-04-10 2021-12-09 추가이 세이야쿠 가부시키가이샤 Fc 영역 개변 항체의 정제 방법
JPWO2022260091A1 (el) 2021-06-10 2022-12-15

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
JP3121823B2 (ja) * 1988-02-12 2001-01-09 ビーティージー・インターナショナル・リミテッド 抗体におけるまたは抗体に関する改良

Also Published As

Publication number Publication date
FI922380A (fi) 1992-05-25
HUT64601A (en) 1994-01-28
ZA918259B (en) 1993-04-16
KR960015399B1 (ko) 1996-11-13
EP0504363A1 (en) 1992-09-23
GB9022547D0 (en) 1990-11-28
NZ244114A (en) 1995-06-27
FR2677997A1 (fr) 1992-12-24
ES2112865T3 (es) 1998-04-16
DE69128774T2 (de) 1998-06-04
PT100988B (pt) 1999-08-31
LU88122A1 (fr) 1993-03-15
NZ240247A (en) 1994-03-25
MX9203794A (es) 1992-07-01
DE69128774D1 (de) 1998-02-26
ATE162552T1 (de) 1998-02-15
JPH05504579A (ja) 1993-07-15
IE913560A1 (en) 1992-04-22
DK0504363T4 (da) 2007-05-29
FI922380A0 (fi) 1992-05-25
FI922824A (fi) 1992-06-17
AU658926B2 (en) 1995-05-04
GR3026588T3 (en) 1998-07-31
CA2069481C (en) 2003-07-29
FI110003B (fi) 2002-11-15
PT99248A (pt) 1993-06-30
IT1250064B (it) 1995-03-30
TW283710B (el) 1996-08-21
GB9209529D0 (en) 1992-07-01
ITRM910788A0 (it) 1991-10-16
FR2668164B1 (el) 1995-04-14
IL99761A0 (en) 1992-08-18
EP0504363B2 (en) 2007-02-07
CA2069481A1 (en) 1992-04-18
ATA900791A (de) 1996-06-15
AU4521897A (en) 1998-02-12
GR910100425A (el) 1992-09-25
KR920703108A (ko) 1992-12-17
AU8729491A (en) 1992-05-20
DE69128774T3 (de) 2007-08-16
ES2081742B1 (es) 1996-10-01
MY136210A (en) 2008-08-29
HU9202000D0 (en) 1992-10-28
IL102726A (en) 2002-08-14
ITRM910788A1 (it) 1993-04-16
MY119030A (en) 2005-03-31
CH681455A5 (el) 1993-03-31
AU649078B2 (en) 1994-05-12
JP2638680B2 (ja) 1997-08-06
BE1004226A5 (fr) 1992-10-13
EP0504363B1 (en) 1998-01-21
IL102726A0 (en) 1993-01-31
ES2112865T5 (es) 2007-09-16
AU716402B2 (en) 2000-02-24
AU7024294A (en) 1995-01-05
WO1992007084A1 (en) 1992-04-30
PT99248B (pt) 1999-04-30
CH681305A5 (el) 1993-02-26
AU2532192A (en) 1993-02-11
GB2253397A (en) 1992-09-09
DK0504363T3 (da) 1998-09-21
PT100988A (pt) 1994-02-28
FI110002B (fi) 2002-11-15
ZA926191B (en) 1993-04-16
KR100193314B1 (ko) 1999-06-15
BR1100358A (pt) 2000-03-28
ES2081742A1 (es) 1996-03-01
FR2668164A1 (fr) 1992-04-24
US5644036A (en) 1997-07-01
FI922824A0 (fi) 1992-06-17

Similar Documents

Publication Publication Date Title
GR920100471A (el) Κα?αρισμένη ανοσογλοβουλίνη.
DE69431209T2 (de) Transdermale prostaglandin-zusammensetzung
MX9206030A (es) Adhesivos resistentes al calor, para adherir ventanillas de piezas postales.
ATE193839T1 (de) Reinigung von proteinen
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
EP0653265A3 (en) Improvements related to friction welding.
NO910922D0 (no) Tris-maleimidoforbindelser som mellomprodukter i trifunksjonell antistoffsyntese.
ES2111031T3 (es) Uso de preparaciones que contienen anticuerpos para la inmunosupresion.
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
DE69206431D1 (de) Härtbare Zusammensetzung.
DK0565631T3 (da) Antivirale forbindelser
MX9102858A (es) Purificacion de polidextrosa mediante cromatografia de exclusion de tamaño.
CH684234GA3 (fr) Calendrier musulman.
NO943748D0 (no) Fremgangsmåte for å isomerisere 2-metyl-3-buten-nitril
AU576911B2 (en) Recovering 2,6-dichlorotoluene from isomers using 2sm-5 zeolite
DE69113750T2 (de) Dimerisierungsverfahren für n-Buten.
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
FR2374911A1 (fr) Adjuvants d'immunite non specifique
NO960849L (no) Difluorstaton-antivirale analoger
NO306343B1 (no) Difluorstaton-analoger
AU4867079A (en) Single or double c-shaped rail clamp
MX9302629A (es) Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad.
ES1020402Y (es) Armadura para mesas.
ITTO910901A1 (it) Procedimento per l'incollaggio di pezzi di lamiera.